Source: Virtual Congress 2021 – Pneumonia



Rating:

Share or cite this content

Citations should be made in the following way:
L. Ruiz Iturriaga (Barakaldo (Bizkaia), Spain), L. Serrano Fernandez (Barakaldo (Bizkaia), Spain), B. Gonzalez Quero (Barakaldo (Bizkaia), Spain), A. Gomez Bonilla (Barakaldo (Bizkaia), Spain), S. Perez Fernandez (Barakaldo (Bizkaia), Spain), A. Rezola Carasusan (Barakaldo (Bizkaia), Spain), A. Artaraz Ereño (Galdakao (Bizkaia), Spain), J. Solorzano Santobeña (Barakaldo (Bizkaia), Spain), I. Gonzalez Muñoz (Barakaldo (Bizkaia), Spain), P. España Yandiola (Galdakao (Bizkaia), Spain), R. Zalacain Jorge (Barakaldo (Bizkaia), Spain). Lymphopenic community acquired pneumococcal pneumonia: Clinical characteristics and outcome. 1749

Member's Comments

No comment yet.

Related content which might interest you: Role of pneumococcus urinary antigen testing in the clinical presentation and outcome of pneumococcal bacteraemic community acquired pneumonia Source: Annual Congress 2011 - Assessment of severity and predictors of outcomes in community-acquired pneumonia Year: 2011 Clinical features of patients with pneumococcal urinary antigen positivity, in a cohort of hospitalised community acquired pneumonia Source: Annual Congress 2012 - Prognostic indices in respiratory infections Year: 2012 Epidemiology, antimicrobial resistance and clinical outcomes in nursing home associated pneumonia compared to community acquired pneumonia Source: Annual Congress 2013 –Antibiotics, resistance and vaccines Year: 2013 Impact of bacterial coinfection on clinical outcomes in pneumococcal pneumonia Source: International Congress 2015 – Pneumonia: determinants of clinical outcomes and potential strategies to improve its management Year: 2015 Clinical characteristics and outcomes of hospitalized COVID-19 pneumonia : impact of gender Source: Virtual Congress 2021 – Clinical features and challenges of COVID-19 Year: 2021 The risk factors of clinical practice for bacteremia in community- acquired pneumococcal pneumonia Source: International Congress 2016 – Community-acquired pneumonia: from prevention to treatment Year: 2016 Severe community acquired pneumonia: clinical and aetiological evaluation Source: Eur Respir J 2007; 30: Suppl. 51, 673s Year: 2007 Community acquired legionella pneumophila pneumonia, clinical characteristics, outcomes and prognostic factors Source: International Congress 2015 – Clinical issues in CAP: microbiological and radiological determinants Year: 2015 Clinical presentation and evolution of community acquired pneumonia in older patients Source: Annual Congress 2012 - Management of pneumonia due to hospital pathogens Year: 2012 Potential protective role of prior to diagnosis antibiotic treatment in community-acquired pneumonia: Clinical presentation and outcomes Source: Annual Congress 2011 - Antimicrobial treatment and resistance in lower respiratory tract infections Year: 2011 Clinical and bacteriological features of hospital acquired pneumonia Source: Eur Respir J 2001; 18: Suppl. 33, 463s Year: 2001 Disagreement in radiological diagnosis of community acquired pneumonia and its impact on management and mortality: Is the term ’pneumonia’ outdated? Source: International Congress 2015 – Clinical issues in CAP: microbiological and radiological determinants Year: 2015 Effects of vaccination on clinical presentation of community acquired pneumonia (CAP) Source: Annual Congress 2013 –Biomarkers, diagnosis and outcome of respiratory infections Year: 2013 Clinical stability in patients with community- acquired pneumonia (CAP) Source: Annual Congress 2011 - New aspects in prevention and treatment of community-acquired pneumonia and lower respiratory tract infections Year: 2011 Microbiological study of community acquired pneumonia versus nosocomial pneumonia in pediatric age group Source: Eur Respir J 2004; 24: Suppl. 48, 714s Year: 2004 Health care associated pneumonia versus community acquired pneumonia: Comparison of etiology, treatment and prognosis Source: Annual Congress 2012 - Viral infections and rare respiratory infections Year: 2012 The presence of diabetes does not influence clinical outcomes in patients with community-acquired pneumonia: results from the community-acquired pneumonia organization (CAPO) international cohort study Source: Annual Congress 2007 - Severity scores and comorbidities in community-acquired pneumonia Year: 2007 Clinical judgement on top of CURB65-score in predicting 30 days clinical outcome in patients with community acquired pneumonia (CAP) admitted to the hospital Source: International Congress 2014 – Pathogenesis and mechanisms of respiratory infections Year: 2014 Clinical features of adults with seven-valent- conjugated-vaccine- serotype pneumococcal pneumonia Source: Annual Congress 2013 –Antibiotics, resistance and vaccines Year: 2013 Late-breaking abstract: The differences in clinical presentations between severe health care-associated pneumonia and severe community-acquired pneumonia: A single center experience Source: Annual Congress 2011 - Aetiology, diagnosis and outcomes in community-acquired pneumonia Year: 2011